The appropriate rate of breast conserving surgery: An evidence-based estimate

Clinical Oncology

Volumn 15, Issue 3, 2003, Pages 144-155

  Tyldesley, S ^a   Foroudi, F ^a   Barbera, L ^a   Boyd, C ^a   Schulze, K ^a   Walker, H ^a   Mackillop, William J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Breast cancer; Breast conservation surgery; Guidelines; Needs assessment; Standards

Indexed keywords

ANALYTICAL ERROR; ARTICLE; BREAST CANCER; BREAST SURGERY; CALCULATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MASTECTOMY; MEDICAL AUDIT; MEDICAL LITERATURE; NORTH AMERICA; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLING; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS;

EID: 0038745629     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2003.0206     Document Type: Article

References (64)

1. Treatment of Early-Stage Breast Cancer. NIH Consensus Statement Online 1990 Jun 18-21 [cited 2001 Sept 27];81-19.
2. Schnitt S, Hayman J, Gelman R, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 1996;77:1094-1100.
3. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-2274.
4. Margolese RG. Breast cancer surgery: who chooses and how? Can Med Assoc J 1994;150:331-333.
5. Paszat LF, Groome PA, Schulze K, Holowaty EJ, Mackillop WJ. A population-based study of the effectiveness of breast conservation for newly diagnosed breast cancer. Int J Rad Onc Biol Phys 2000;46:345-353.
6. Tyldesley S, Zhang-Salomons J, Groome P, et al. The association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 2000;47:469-480.
7. Wilson RG, Hart A, Dawes PJDK. Mastectomy of conservation: the patient's choice. BMJ 1988;297:1167-1172.
8. Fallowfield LJ, Hall A, Maguire GP, et al. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 1990;301:575-580.
9. Goel V, Olivotto I, Hislop G, et al. Patterns of initial management of node-negative breast cancer in two Canadian provinces. Can Med Assoc J 1997;156:25-35.
10. Bland KI, Menck HR, Scott-Conner CEH, et al. The national cancer database 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-1273.
11. Tarbox BB, Rockwood JK, Abernathy CM. Are modified radical mastectomies done for T1 breast cancers because of surgeon's advice or patient's choice. Am J Surg 1992;164:417-420.
12. Tyldesley S, Boyd C, Schulze K, Walker H, Mackillop WJ. Estimating the need for radiotherapy for lung cancer: an evidence-based epidemiologic approach. Int J Radiat Oncol Biol Phys 2001;49:973-985.
13. Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of the appropriate radiotherapy utilization for breast cancer. Int J Radiat Oncol Biol Phys 2002;53:1240-1253.
14. Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence-based estimate of the appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys 2002; in press.
15. Wright J. Health Needs Assessment in Practice. London: BMJ Publishing Group, 1998.
16. Sanderson C, Hunter D, McKee M, et al. Limitations of epidemiologically based needs assessment: the case of prostatectomy. Med Care 1997;35:669-685.
17. National Cancer Institute. CancerNet: A service of the National Cancer Institute: PDQ Cancer Information Summaries: Treatment. Monograph on line. Accessed Sept/01. (URL: http://cancernet.nci.nih.gov/pdq/pdq_treatment.shtml).
18. Cancer Care Ontario Practice Guidelines Initiative. Breast Cancer Clinical Practice Guidelines. Monograph on line. Accessed Sep/01. (url: http://hiru.mcmaster.ca/ccopgi/lungcpg.html).
19. Anonymous. Clinical practice guidelines for the care and treatment of breast cancer: a Canadian consensus document. Can Med Assoc J 1998;158.
20. Anonymous. Early stage breast cancer-NIH consensus conference. J A M A 1991;265:391-395.
21. Carlson RW, Goldstein LJ, Gradishar WJ, et al. Update of the NCCN guidelines for treatment of breast cancer. Oncology 1997;11:199-220.
22. British Columbia Cancer Agency. Cancer Management Manual. Monograph on line. Accessed Dec/99. (url: http://www.bccancer.bc.ca/cmm/lung/).
23. Harris DM, Lippman ME, Morrow M, et al. Diseases of the Breast, 2nd edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2000.
24. Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. Ca: a Cancer. J Clinicians 1998;48:83-107.
25. American College of Radiology Task Force on Appropriateness Criteria. Appropriateness Criteria for Imaging and Treatment Decisions in Radiation Oncology. Reston, VA: American College of Radiology, 1999.
26. Scottish Intercollegiate Guidelines Network. Management of Breast Cancer. Monograph on line. Accessed Sept/01. (url: http://www.show.scot.nhs.uk/sign/pdf/sign29.pdf).
27. Royal College of Radiologists Clinical Oncology Information Network (COIN). Guidelines on the non-surgical management of breast cancer. Monogram on line. Accessed Sept/01 (url:http://www.rcr.ac.uk/breast.pdf).
28. BASO Breast Surgeons Group. The guidelines for surgeons in the management of symptomatic breast disease. Eur J Surg Oncol 1996;22:465-476.
29. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95(Suppl. 2):2S-4S.
30. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1998), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2001, based on the August 2000 submission.
31. Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: a computer approach. In: Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG, eds. Cancer Registration Principles and Methods. Lyon, France: International Agency for Research on Cancer, 1991;246-257.
32. Bishop YMM, Fienberg SE, Holland PW. Discrete Multivariate Analysis: theory and Practice. Cambridge, MA: The MIT Press, 1975.
33. Fisher E, Leeming R, Anderson S, et al. Conservative management of intra-ductal carcinoma (DCIS) of the breast. Collaborating NSABP Investigators. J Surg Oncol 1991;47(S):139-147.
34. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-452.
35. Morrow M, Bucci C, Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 1998;186:269-274.
36. White TT. Carcinoma of the breast in the pregnant and the nursing patient. Am J Obst Gynec 1955;69:1277-1286.
37. Morrow M, Schmidt R, Hassett C. Patient selection for breast conservation therapy with magnification mammography. Surgery 1995;118:621-626.
38. Blair SL, O'Shea KE, Orr RK. Surgeon variability in treating nonpalpable breast cancer: surgical oncology as a value-added specialty. Ann Surg Onc 1998;5:28-32.
39. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539-1545.
40. Smith IE, Walsh G, Jones A, et al. High complete remission rates with primary neoadjuvant chemotherapy for large early breast cancer. J Clin Oncol 1995;13:424-429.
41. Guadagnoli E, Weeks JC, Shapiro CL, et al. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 1998;16:101-106.
42. Polednak AP. Epidemiology of breast cancer in Connecticut women. Connecticut Med 1999;63:7-16.
43. Applewhite RR, Smith L, DiVincenti F. Cancer of the breast associated with pregnancy and lactation. Am Surg 1973;39:101-104.
44. Devitt JE, Beattie WG, Stoddart TG. Cancer of the breast and pregnancy. Can J Surg 1964;7:124-128.
45. Wilson LD, Beinfield M, McKhann CF, et al. Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers. Cancer 1993;72:137-142.
46. Johnson AE, Gordon C, Palmer RG, et al. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Arthritis Rheum 1995;38:551-558.
47. Roy S, Feehally J, Symmons DPM. The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester City, UK. Br J Rheum 1992;31:679-682.
48. Lawrence R, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-799.
49. Maricq HR, Weinrich MC, Keil JE, et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998-1005.
50. Fisher E, Anderson S, Redmond CK, et al. Re-analysis and results after 12 years of follow-up in a randomized trial comparing total mastectomy with lumpectomy, with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-1461.
51. Jacobsen JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of Stage I and II breast cancer. N Eng J Med 1995;332:907-911.
52. Van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast conserving therapy in Stage I and Stage II breast cancer: EORTC 10801 Trial. J Natl Ca Inst Monogram 1992;11:15-18.
53. Blichert-Toft M, Rose C, Anderson JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. J Natl Ca Inst Monogram 1992;11:19-25.
54. Arriagada R, Le MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data. JCO 1996;14:1558-1564.
55. Veronesi U, Luini A, Galimberti V, Zurrida S. Conservative approaches to the management of Stage I/II carcinoma of the breast: Milan Cancer Institute Trials. World J Surg 1994;18:70-5.
56. Fisher B, Brown A, Manounas E, et al. Effect of preoperative chemotherapy on loco-regional disease in women with operable breast cancer: Findings from National Surgical Breast and Bowel Project B-18. JCO 1997;15:2483-2493.
57. Mascarel DI, Bonichon F, MacGrogan G, et al. Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: Practical considerations. Br Cancer Res Treat 2000;61:151-159.
58. Holland PA, Gandhi A, Knox WF, et al. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer 1998;77:110-114.
59. Ernster VL, Barclay J, Kerlikowske, et al. Incidence and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-918.
60. Goel V, Sawka CA, Thiel EC, Gort EH, O'Conner AM. Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. Med Decision Making 2001;21:1-6.
61. Whelan T, Levine M, Gafni A, et al. Mastectomy or Lumpectomy? Helping women make informed choices. J Clin Oncol 1999;17:1727-1735.
62. Molenaar S, Sprangers MAG, Rutgers EJTH, et al. Decision support for patients with early-stage breast cancer: effects of an Interactive Breast Cancer CDROM on Treatment decision, Satisfaction, and Quality of Life. J Clin Oncol 2001;19:1676-1687.
63. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992;326:1097-1101.
64. Hahn CA, Marks LB, Chen DY, et al. Breast conservation rates - barriers between tertiary care and community practice. Int J Radiat Oncol Biol Phys 2001;51(S1):87.